PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV
Status:
Completed
Trial end date:
2017-01-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of rectal lubricants can affect how
well the medication, Truvada, will work to prevent infection with HIV when someone is exposed
to HIV in the rectum.
Phase:
Phase 4
Details
Lead Sponsor:
Emory University
Collaborator:
Centers for Disease Control and Prevention
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir